Drug Discovery
QIAGEN Advances Drug Discovery with AI-Driven Biomedical Knowledge Base Featuring 640 Million Relationships
QIAGEN Biomedical KB-AI contains over 640 million biomedical relationships, including gene, disease and drug causal relationships, to aid in data-dr...
March 04, 2024 | News
SN Bioscience's SNB-101 Granted FDA Orphan Drug Designation for Pancreatic Cancer Treatment
SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on Feb 27 that the US FDA had granted an orphan drug designation for pancreatic cance...
March 01, 2024 | News
Waters Launches HPLC/UPLC-MALS Integration Software for Advanced Biologic Drug Characterization
At Pittcon 2024, Waters Corporation (NYSE:WAT) unveiled the HPLC CONNECT software, a comprehensive software solution designed to facilitate seamless digita...
February 29, 2024 | News
Teva Partners with Jiangsu Nhwa to Enhance AUSTEDO® Access in China
“Nhwa has deep neuro-psychiatry expertise and capabilities, from research and development to commercialization,” commented Theodor Wee,...
February 28, 2024 | News
BioCina and NovaCina Join Forces for Integrated Biologics Solutions
BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organisation (CDMO), and NovaCina Pty Ltd., a global fill-and-finish...
February 28, 2024 | News
Neomorph, Novo Nordisk Partner on Molecular Glue Degraders for Diseases
Collaboration leverages Neomorph's leading molecular glue discovery platform and Novo Nordisk's extensive expertise in cardiometabolic and rare diseases ...
March 27, 2024 | News
Charles River and Wheeler Bio Forge Strategic Alliance to Streamline Drug Development Process
This partnership aims to enhance therapeutic discovery and expedite the journey to Investigational New Drug (IND) submission by combining Charles R...
February 23, 2024 | News
Ono Pharmaceutical Partners with InveniAI to Revolutionize Drug Discovery Using AI
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") has announced a strategic partnership with the AI-driven company InveniAI...
February 22, 2024 | News
Hox Therapeutics and Vernalis Enter Collaboration to Advance Oncology Drug Discovery
Hox Therapeutics Ltd, a pioneering biotechnology company dedicated to developing targeted cancer therapies, and Vernalis (R&D) Ltd, a renowned subsidia...
February 22, 2024 | News
Japan Becomes First in the World to Approve Dupixent® for Chronic Spontaneous Urticaria (CSU)
Approval based primarily on results from Phase 3 trial showing Dupixent significantly reduced itch compared to placebo CSU is the fifth appr...
February 17, 2024 | News
FDA Prioritizes Review of Bristol Myers Squibb's Augtyro™ for NTRK-Positive Solid Tumors
Bristol Myers Squibb (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for A...
February 15, 2024 | News
GSK Secures License for Elsie Biotechnologies' Cutting-Edge Discovery Platform
Kevin Green, Chief Operating Officer of Elsie Biotechnologies, expressed enthusiasm, stating, "We are pleased that GSK ha...
February 15, 2024 | News
Atara Biotherapeutics Submits Investigational New Drug Application for ATA3219 to Treat Lupus Nephritis
Lupus nephritis, a condition affecting the kidneys, presents a challenging treatment landscape with limited efficacy from existing therapies. ATA32...
February 15, 2024 | News
BioAge Secures $170 Million in Series D Funding to Propel Obesity and Metabolic Disease Drug Development
BioAge Labs (“BioAge”), a pioneering biotechnology firm dedicated to advancing novel treatments for obesity and metabolic diseases by e...
February 14, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
